Jilin Province Huinan Changlong Bio-pharmacy Company Limited (8049.HK)
HKD 1.39
(-0.71%)
HKD 1.39
(-0.71%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 102.97 Million CNY | -22.57% |
| 2022 | 132.98 Million CNY | 54.08% |
| 2021 | 86.31 Million CNY | 56.93% |
| 2020 | 55 Million CNY | 9.68% |
| 2019 | 50.14 Million CNY | -4.41% |
| 2018 | 52.45 Million CNY | 3.42% |
| 2017 | 50.72 Million CNY | 94.67% |
| 2016 | 26.05 Million CNY | -9.42% |
| 2015 | 28.76 Million CNY | -14.48% |
| 2014 | 33.63 Million CNY | 31.48% |
| 2013 | 25.58 Million CNY | -27.62% |
| 2012 | 35.34 Million CNY | 16.69% |
| 2011 | 30.28 Million CNY | 29.97% |
| 2010 | 23.3 Million CNY | -43.79% |
| 2009 | 41.45 Million CNY | 118.49% |
| 2008 | 18.97 Million CNY | -8.3% |
| 2007 | 20.69 Million CNY | 9.02% |
| 2006 | 18.98 Million CNY | -13.88% |
| 2005 | 22.04 Million CNY | -3.99% |
| 2004 | 22.95 Million CNY | -12.21% |
| 2003 | 26.15 Million CNY | -18.65% |
| 2002 | 32.14 Million CNY | 16.48% |
| 2001 | 27.59 Million CNY | 4.88% |
| 2000 | 26.31 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 82.35 Million CNY | -20.02% |
| 2024 Q2 | 82.35 Million CNY | 0.0% |
| 2023 Q2 | 113.51 Million CNY | 0.0% |
| 2023 Q3 | - CNY | -100.0% |
| 2023 Q1 | - CNY | -100.0% |
| 2023 FY | 102.97 Million CNY | -22.57% |
| 2023 Q4 | 102.97 Million CNY | 0.0% |
| 2022 FY | 132.98 Million CNY | 54.08% |
| 2022 Q4 | 132.98 Million CNY | 0.0% |
| 2022 Q3 | - CNY | -100.0% |
| 2022 Q1 | - CNY | -100.0% |
| 2022 Q2 | 104.54 Million CNY | 0.0% |
| 2021 FY | 86.31 Million CNY | 56.93% |
| 2021 Q2 | 112.09 Million CNY | 0.0% |
| 2021 Q1 | - CNY | -100.0% |
| 2021 Q4 | 86.31 Million CNY | 0.0% |
| 2020 FY | 55 Million CNY | 9.68% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 Q2 | 46.92 Million CNY | 0.0% |
| 2020 Q4 | 55 Million CNY | 0.0% |
| 2019 Q4 | 50.14 Million CNY | 0.0% |
| 2019 Q2 | 52.32 Million CNY | 0.0% |
| 2019 FY | 50.14 Million CNY | -4.41% |
| 2018 Q1 | - CNY | -100.0% |
| 2018 Q4 | 52.45 Million CNY | 0.0% |
| 2018 Q2 | 57.29 Million CNY | 0.0% |
| 2018 FY | 52.45 Million CNY | 3.42% |
| 2017 Q2 | 36.45 Million CNY | 0.0% |
| 2017 Q4 | 50.72 Million CNY | 0.0% |
| 2017 FY | 50.72 Million CNY | 94.67% |
| 2017 Q1 | - CNY | -100.0% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 FY | 26.05 Million CNY | -9.42% |
| 2016 Q4 | 26.05 Million CNY | 0.0% |
| 2016 Q2 | 38.21 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 Q2 | 37.07 Million CNY | 0.0% |
| 2015 Q4 | 28.76 Million CNY | 0.0% |
| 2015 FY | 28.76 Million CNY | -14.48% |
| 2014 Q4 | 33.63 Million CNY | 0.0% |
| 2014 FY | 33.63 Million CNY | 31.48% |
| 2014 Q2 | 31.16 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2013 Q1 | - CNY | -100.0% |
| 2013 Q4 | 25.58 Million CNY | 0.0% |
| 2013 Q2 | 30 Million CNY | 0.0% |
| 2013 FY | 25.58 Million CNY | -27.62% |
| 2012 Q4 | 35.34 Million CNY | 0.0% |
| 2012 Q2 | 37.56 Million CNY | 0.0% |
| 2012 FY | 35.34 Million CNY | 16.69% |
| 2011 Q4 | 30.28 Million CNY | 0.0% |
| 2011 FY | 30.28 Million CNY | 29.97% |
| 2011 Q2 | 28.68 Million CNY | 0.0% |
| 2010 Q4 | 23.3 Million CNY | 0.0% |
| 2010 Q2 | 22.54 Million CNY | 0.0% |
| 2010 FY | 23.3 Million CNY | -43.79% |
| 2009 FY | 41.45 Million CNY | 118.49% |
| 2008 FY | 18.97 Million CNY | -8.3% |
| 2007 FY | 20.69 Million CNY | 9.02% |
| 2006 FY | 18.98 Million CNY | -13.88% |
| 2005 FY | 22.04 Million CNY | -3.99% |
| 2004 FY | 22.95 Million CNY | -12.21% |
| 2003 FY | 26.15 Million CNY | -18.65% |
| 2002 FY | 32.14 Million CNY | 16.48% |
| 2001 FY | 27.59 Million CNY | 4.88% |
| 2000 FY | 26.31 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -744.24% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 92.585% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -1317.371% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 66.578% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 76.152% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 65.458% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -63.911% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -4.789% |
| PuraPharm Corporation Limited | 175.59 Million HKD | 41.359% |
| SSY Group Limited | 1.08 Billion HKD | 90.521% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -12.433% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 67.604% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.707% |